{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:15:01Z","timestamp":1785802501891,"version":"3.56.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T00:00:00Z","timestamp":1425600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T00:00:00Z","timestamp":1425600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00228-015-1813-3","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T01:31:23Z","timestamp":1425519083000},"page":"611-615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants"],"prefix":"10.1007","volume":"71","author":[{"given":"M\u00e9lanie","family":"Sicard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Caillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Jacqueline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Deslandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Roz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christ\u00e8le Gras-Le","family":"Guen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,6]]},"reference":[{"key":"1813_CR1","unstructured":"ANAES (2002) Recommandation pour la pratique clinique: Diagnostic et traitement curatif de l\u2019infection bact\u00e9rienne pr\u00e9coce du nouveau-n\u00e9"},{"key":"1813_CR2","first-page":"95","volume":"3","author":"A Beiras-Fernandez","year":"2010","unstructured":"Beiras-Fernandez A, Vogt F, Sodian R et al (2010) Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens. Infect Drug Resist 3:95\u2013101","journal-title":"Infect Drug Resist"},{"key":"1813_CR3","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/INF.0b013e3181acf6bd","volume":"28","author":"M Cohen-Wolkowiez","year":"2009","unstructured":"Cohen-Wolkowiez M, Moran C, Benjamin DK et al (2009) Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J 28:1052\u20131056","journal-title":"Pediatr Infect Dis J"},{"key":"1813_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/01.inf.0000186283.95728.34","volume":"24","author":"DAC Fratarelli","year":"2005","unstructured":"Fratarelli DAC, Ergun H, Lulic-Botica M et al (2005) Vancomycin elimination in human infants with intra uterine growth retardation. Pediatr Infect Dis J 24:979\u2013983","journal-title":"Pediatr Infect Dis J"},{"issue":"S2","key":"1813_CR5","first-page":"ii45","volume":"51","author":"G French","year":"2003","unstructured":"French G (2003) Safety and tolerability of linezolid. J Antimicrob Chemother 51(S2):ii45\u2013ii53","journal-title":"J Antimicrob Chemother"},{"key":"1813_CR6","doi-asserted-by":"publisher","first-page":"e883","DOI":"10.1542\/peds.2010-2442","volume":"127","author":"I Guellec","year":"2011","unstructured":"Guellec I, Lapillonne A, Renolleau S et al (2011) Neurological outcomes at school age in very preterm infants born with severe or mild growth restriction. Pediatrics 127:e883\u2013e891","journal-title":"Pediatrics"},{"key":"1813_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.earlhumdev.2006.07.008","volume":"84","author":"T Honzik","year":"2006","unstructured":"Honzik T, Wenchich L, B\u00f6hm M et al (2006) Activities of respiratory chain complexes and pyruvate dehydrogenase in isolated muscle mitochondria in premature neonates. Early Hum Dev 84:269\u2013276","journal-title":"Early Hum Dev"},{"key":"1813_CR8","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1128\/AAC.46.12.3706-3711.2002","volume":"46","author":"C Jacqueline","year":"2002","unstructured":"Jacqueline C, Batard E, Perez L et al (2002) In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model. Antimicrob Agents Chemother 46:3706\u20133711","journal-title":"Antimicrob Agents Chemother"},{"key":"1813_CR9","doi-asserted-by":"crossref","unstructured":"Jones RN, Stilwell MG, Hogan PA et al (2007) LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers). Diag Microbiol Infect Dis 309\u2013317","DOI":"10.1016\/j.diagmicrobio.2007.06.004"},{"key":"1813_CR10","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1097\/01.inf.0000086954.43010.63","volume":"22","author":"GL Jungbluth","year":"2003","unstructured":"Jungbluth GL, Welshman IR, Hopkins NK (2003) Linezolid pharmacokinetics in pediatric patients: an overview. Pediatr Infect Dis J 22:S153\u2013S157","journal-title":"Pediatr Infect Dis J"},{"key":"1813_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/01.inf.0000078160.29072.42","volume":"22","author":"SL Kaplan","year":"2003","unstructured":"Kaplan SL, Deville JG, Yogev R et al (2003) Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J 22:677\u2013685","journal-title":"Pediatr Infect Dis J"},{"key":"1813_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0009-9236(03)00226-1","volume":"74","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Jungbluth GL, Abdel-Rahman SM et al (2003) Impact of ontogeny on linezolid disposition in neonates and infants. Clin Pharmacol Ther 74:413\u2013422","journal-title":"Clin Pharmacol Ther"},{"key":"1813_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jpeds.2010.08.019","volume":"158","author":"S McKamy","year":"2011","unstructured":"McKamy S, Hernandez E, Jahng M et al (2011) Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children. J Pediatr 158:422\u2013426","journal-title":"J Pediatr"},{"key":"1813_CR14","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1097\/01.inf.0000087021.20838.d9","volume":"22","author":"HC Meissner","year":"2003","unstructured":"Meissner HC, Towsend T, Wenman W et al (2003) Hematologic effects of linezolid in young children. Pediatr Infect Dis J 22:S186\u2013S192","journal-title":"Pediatr Infect Dis J"},{"key":"1813_CR15","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1097\/01.inf.0000087022.58089.d8","volume":"22","author":"L Saiman","year":"2003","unstructured":"Saiman L, Goldfarb J, Kaplan SA et al (2003) Safety and tolerability of linezolid in children. Pediatr Infect Dis J 22:S193\u2013S200","journal-title":"Pediatr Infect Dis J"},{"key":"1813_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1067\/mpd.2001.119442","volume":"139","author":"AH Sohn","year":"2001","unstructured":"Sohn AH, Garrett DO, Sinkowitz-Cochran RL et al (2001) Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the First National Point-Prevalence Survey. J Pediatr 139:821\u2013827","journal-title":"J Pediatr"},{"key":"1813_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/INF.0b013e3182186035","volume":"30","author":"E Su","year":"2011","unstructured":"Su E, Crowley K, Carcillo JA, Michaels MG (2011) Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children. Pediatr Infect Dis J 30:804\u2013806","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"1813_CR18","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/AAC.42.12.3251","volume":"42","author":"SM Swaney","year":"1998","unstructured":"Swaney SM, Aoki H, Ganoza MC et al (1998) The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 42(12):3251\u20133255","journal-title":"Antimicrob Agents Chemother"},{"key":"1813_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000226604","volume":"97","author":"A Van den Hoogen","year":"2010","unstructured":"Van den Hoogen A, Gerards LJ, Verboon-Maciolek MA et al (2010) Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology 97:22\u201328","journal-title":"Neonatology"},{"key":"1813_CR20","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1517\/14656566.8.14.2381","volume":"8","author":"KZ Vardakas","year":"2007","unstructured":"Vardakas KZ, Ntziora F, Falagas ME (2007) Linezolid: effectiveness and safety for approved and off-label indications. Expert Opin Pharmacother 8:2381\u20132400","journal-title":"Expert Opin Pharmacother"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1813-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-015-1813-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1813-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1813-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:38:48Z","timestamp":1744173528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-015-1813-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,6]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1813"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1813-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,6]]},"assertion":[{"value":"17 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}